TLV Equity Snapshot

XTLB Weekly Equity Report

XTL Biopharmaceuticals Ltd.

Interactive chart JSON snapshot
Latest Close 1.70 ILA 12 Jun 2026
1W Return 0.0% latest completed week
4W Return 8400.0% short-term follow-through
12W Return 7995.2% quarterly tape
Trend Breadth 9.6% 5 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
Company Brief

What the company does

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. Its lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. The company has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in …

Snapshot

What the weekly tape is saying

XTLB closed the latest completed week at 1.70 ILA. The 4-week return is 8400.0% and the 12-week return is 7995.2%. Trend Signal is active, Market Dynamics is 1.56. Setup signature: Balanced read with a 59/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 558.5%
Volume 1.0x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 19 Persistence of active Trend Signal over the last year and current streak.
Momentum 100 Blend of 4-week and 12-week follow-through.
Dynamics 93 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 100 Relative leadership and short-term RS change.
Volume 44 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
0.26 ILA
Vs Trend Line
558.5%
Fair Value
0.10 ILA
Vs Fair Value
1688.5%
52W High
2.10 ILA
52W Low
0.02 ILA
Drawdown
-19.0%
Range Position
80.8%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 0.0%
4W 8400.0%
12W 7995.2%
26W 5566.7%
52W 4150.0%

Trend read

Active Streak
4 weeks
52W Active Weeks
5
52W Active Breadth
9.6%
Sector Scope
IL Healthcare
Sector Rank
29 of 51
Sector Percentile
44.0%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
1.56
4W MD Change
185.7%
Relative Strength
865.64
4W RS Change
1638.7%
Expectation
Negative
Probability
36.29%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
20.9M
13W Average
20.1M
52W Average
18.3M
Vs 13W
1.0x
Vs 52W
1.1x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
2504.8%
52W Volatility
1291.1%
Upside Weeks
15
Downside Weeks
29
Downside Breadth
55.8%
Avg Gain / Loss
641.5% / -8.8%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
TLV
Country
IL
Sector
Healthcare
Industry
Biotechnology
Currency
ILA
Market Cap
17.0M

Opportunity signals

  • Trend Signal is active with a 4-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Market Dynamics is positive on the latest completed week.

Risk signals

  • Recent volatility is running well above the one-year baseline.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 1.70 ILA 0.0% 0.26 ILA 0.10 ILA 1.56 865.64 20.9M On
5 Jun 2026 1.70 ILA -5.6% 0.20 ILA 0.08 ILA 1.31 1096.54 13.5M On
29 May 2026 1.80 ILA -5.3% 0.15 ILA 0.07 ILA 1.15 1459.03 12.4M On
22 May 2026 1.90 ILA 9400.0% 0.09 ILA 0.06 ILA 1.20 2246.00 19.7M On
15 May 2026 0.02 ILA -4.8% 0.03 ILA 0.05 ILA 0.55 -56.26 20.1M Off
8 May 2026 0.02 ILA -32.3% 0.03 ILA 0.05 ILA 0.37 -56.41 40.7M Off
1 May 2026 0.03 ILA 55.0% 0.03 ILA 0.05 ILA 0.12 -35.83 107.8M Off
24 Apr 2026 0.02 ILA 5.3% 0.03 ILA 0.05 ILA -0.37 -58.91 1.4M Off
17 Apr 2026 0.02 ILA -5.0% 0.03 ILA 0.05 ILA -0.15 -62.25 6.4M Off
10 Apr 2026 0.02 ILA 0.0% 0.03 ILA 0.05 ILA -0.14 -61.48 2.1M Off
3 Apr 2026 0.02 ILA -4.8% 0.03 ILA 0.05 ILA -0.20 -60.05 3.3M Off
27 Mar 2026 0.02 ILA 0.0% 0.03 ILA 0.05 ILA -0.19 -58.08 10.1M Off
20 Mar 2026 0.02 ILA 0.0% 0.03 ILA 0.05 ILA -0.19 -60.94 3.3M Off
13 Mar 2026 0.02 ILA 0.0% 0.03 ILA 0.05 ILA -0.05 -60.47 4.1M Off